Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab
F. Menzella (Reggio Emilia, Italy), M. Aliani (Bari, Italy), E. Altieri (Garbagnate Milanese (MI), Italy), P. Bracciale (Ostuni (BR), Italy), S. Centanni (Milano, Italy), F. De Michele (Napoli, Italy), F. Di Marco (Bergamo, Italy), G. Pelaia (Catanzaro, Italy), M. Romagnoli (Treviso, Italy), P. Schino (Bari, Italy), S. Boarino (Basiglio (MI), Italy), G. Vitiello (Basiglio (MI), Italy), P. Rogliani (Roma, Italy)
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Menzella (Reggio Emilia, Italy), M. Aliani (Bari, Italy), E. Altieri (Garbagnate Milanese (MI), Italy), P. Bracciale (Ostuni (BR), Italy), S. Centanni (Milano, Italy), F. De Michele (Napoli, Italy), F. Di Marco (Bergamo, Italy), G. Pelaia (Catanzaro, Italy), M. Romagnoli (Treviso, Italy), P. Schino (Bari, Italy), S. Boarino (Basiglio (MI), Italy), G. Vitiello (Basiglio (MI), Italy), P. Rogliani (Roma, Italy). Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab. 3735
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: